Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Oral vinorelbine: feasibility and safety profile
A Depierre, G Freyer, J Jassem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1993
Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy
P Fumoleau, F M Delgado, T Delozier, et al.
The Journal of Infectious Diseases
|
September 9, 1999
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains
P G Auwaerter, P A Rota, W R Elkins, et al.
Bone Marrow Transplantation
|
November 27, 2007
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer
P Biron, M Durand, H Roché, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes
P Fumoleau, F Chauvin, M Namer, et al.
Bulletin Du Cancer
|
January 1, 1997
[Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial]
T Delozier, O Switsers, J Y Génot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2000
Delayed adjuvant tamoxifen: ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial)
T Delozier, O Switsers, J Y Génot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group
T Delozier, M Spielmann, J Macé-Lesec'h, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer
A Dezellus, P Barriere, M Campone, et al.
British Journal of Cancer
|
October 3, 1999
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)
P Viens, T Palangié, M Janvier, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2002
Oral vinorelbine: feasibility and safety profile
A Depierre, G Freyer, J Jassem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1993
Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy
P Fumoleau, F M Delgado, T Delozier, et al.
The Journal of Infectious Diseases
|
September 9, 1999
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains
P G Auwaerter, P A Rota, W R Elkins, et al.
Bone Marrow Transplantation
|
November 27, 2007
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer
P Biron, M Durand, H Roché, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Intensification of adjuvant chemotherapy: 5-year results of a randomized trial comparing conventional doxorubicin and cyclophosphamide with high-dose mitoxantrone and cyclophosphamide with filgrastim in operable breast cancer with 10 or more involved axillary nodes
P Fumoleau, F Chauvin, M Namer, et al.
Bulletin Du Cancer
|
January 1, 1997
[Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial]
T Delozier, O Switsers, J Y Génot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2000
Delayed adjuvant tamoxifen: ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial)
T Delozier, O Switsers, J Y Génot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group
T Delozier, M Spielmann, J Macé-Lesec'h, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 3, 2017
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer
A Dezellus, P Barriere, M Campone, et al.
British Journal of Cancer
|
October 3, 1999
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)
P Viens, T Palangié, M Janvier, et al.
Page
of 5